What planet are you JP?
I mean really – when I read your Economist interview I had to laugh… you really are in your own little world aren’t you. Things are not good at Glaxo. That share price really should be much, much higher – especially given what you think you’re worth!
I read: Another reason Mr Garnier is smiling is that GSK has the strongest drugs pipeline of any big firm. It has 33 drugs in the late stage of clinical trials, with perhaps two dozen due to be launched between now and the end of 2009. That is much better than at rival firms, and far better than the pitiful prospects Mr Garnier inherited when he took over as boss of SmithKline Beecham in 2000, just before the merger with Glaxo Wellcome. The industry’s poor research output has led some critics to argue that the huge mergers of the past decade have produced giant firms that are too big and bloated to innovate. Mr Garnier disagrees. “R&D productivity is not linked to size,” he insists. He invokes the image of a successful sumo wrestler and says giants can be nimble if they are clever. Indeed, size can be an advantage in marketing, or when organising massive clinical trials, he observes.
So tell me JP – if R&D is so important why does Glaxo have to spend 2-3 times as much on advertising and marketing as it does on R&D?
I’ve said this before and I’ll say it again – are you listening this time JP? – problem is that the Big Pharma model has become unsustainable… the age of the glorious blockbuster drug is over – gone – finished.
You know it.
You boast of 33 drugs in late stage clinical trials, with perhaps 24 due to be launched in the next two years… I ask how many of them will be safe and effective?
How many of them will end up being used by the public with no safety issues or scandals?
With no deaths associated with their use?
With no litigation?
And as for the clinical trials, I really don’t think you of all people should draw any attention to your ‘clinical trials’… for those of you who don’t know how Glaxo use data from their clinical trials see Doctoring the Evidence: GlaxoSmithKline Pushes Depression Drug and While we’re on the subject of Marty Keller… and And while we’re talking about Study 329 – here are some real Seroxat Secrets
I hear that you’re an arrogant man, JP. That your first instinct is to fight… well, you’ve got a fight on your hands – we’re not going away.
One last question JP – are you a hero yet? (“I’ll be a hero in three years” Jean-Pierre Garnier 5 April 2004)